ResMed Correlations
| RME Stock | EUR 218.10 1.20 0.55% |
The current 90-days correlation between ResMed Inc and Hellenic Telecommunications Organization is 0.01 (i.e., Significant diversification). The correlation of ResMed is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
ResMed Correlation With Market
Weak diversification
The correlation between ResMed Inc and DJI is 0.35 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding ResMed Inc and DJI in the same portfolio, assuming nothing else is changed.
ResMed |
The ability to find closely correlated positions to ResMed could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ResMed when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ResMed - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ResMed Inc to buy it.
Moving together with ResMed Stock
| 0.61 | IUI1 | Intuitive Surgical | PairCorr |
| 0.97 | RMEA | Resmed Inc DRC | PairCorr |
| 0.68 | 56S1 | Sartorius Stedim Biotech | PairCorr |
| 0.87 | LIE | Sun Life Financial | PairCorr |
| 0.83 | 74G | DIVIDEND GROWTH SPLIT | PairCorr |
| 0.76 | VP3 | VIETNAM ENTERPRISE INV | PairCorr |
| 0.75 | SH7 | HELIOS TECHS INC | PairCorr |
| 0.91 | E908 | Lyxor 1 | PairCorr |
| 0.92 | DBPE | Xtrackers LevDAX | PairCorr |
Moving against ResMed Stock
| 0.92 | DBPD | Xtrackers ShortDAX | PairCorr |
| 0.84 | BOX | Becton Dickinson | PairCorr |
| 0.49 | ADC | AdCapital AG | PairCorr |
| 0.45 | KWE1 | Ring Energy | PairCorr |
Related Correlations Analysis
| 0.59 | 0.45 | 0.51 | 0.64 | 0.25 | 0.48 | RKET | ||
| 0.59 | 0.49 | 0.78 | 0.19 | 0.55 | 0.87 | N4Q1 | ||
| 0.45 | 0.49 | 0.6 | 0.56 | 0.21 | 0.46 | E4C | ||
| 0.51 | 0.78 | 0.6 | 0.35 | 0.55 | 0.87 | 6IC | ||
| 0.64 | 0.19 | 0.56 | 0.35 | 0.04 | 0.14 | OTE | ||
| 0.25 | 0.55 | 0.21 | 0.55 | 0.04 | 0.54 | ZCH | ||
| 0.48 | 0.87 | 0.46 | 0.87 | 0.14 | 0.54 | EV9 | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Risk-Adjusted Indicators
There is a big difference between ResMed Stock performing well and ResMed Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze ResMed's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| RKET | 1.55 | 0.15 | (0.04) | 11.67 | 1.63 | 4.52 | 12.23 | |||
| N4Q1 | 0.90 | 0.21 | (0.06) | (0.20) | 1.12 | 2.91 | 10.51 | |||
| E4C | 1.07 | 0.15 | (0.04) | 4.44 | 1.24 | 2.38 | 11.95 | |||
| 6IC | 2.14 | 0.25 | 0.05 | 0.58 | 3.10 | 6.11 | 24.39 | |||
| OTE | 0.69 | 0.16 | (0.05) | 8.35 | 0.73 | 2.28 | 5.89 | |||
| ZCH | 0.81 | 0.13 | 0.00 | (6.88) | 0.00 | 0.00 | 26.83 | |||
| EV9 | 2.75 | 0.53 | 0.06 | (1.17) | 2.68 | 6.54 | 19.32 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in ResMed without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Economic Indicators Now
Economic IndicatorsTop statistical indicators that provide insights into how an economy is performing |
| All Next | Launch Module |
ResMed Corporate Management
Elected by the shareholders, the ResMed's board of directors comprises two types of representatives: ResMed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ResMed. The board's role is to monitor ResMed's management team and ensure that shareholders' interests are well served. ResMed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ResMed's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Amy Wakeham | VP Communications | Profile | |
| Brett Sandercock | Chief Officer | Profile | |
| BE MBA | CEO Director | Profile | |
| Robert Douglas | Pres COO | Profile | |
| Vered Keisar | Chief Officer | Profile | |
| AM AM | Founder Chairman | Profile | |
| David Pendarvis | Global Officer | Profile |